Agoracom: Small Cap Investment - Resverlogix Corp. - Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

Rservlogix large

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free

Reply New Message

Back To Forum List View

FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

5

Apr 05, 2022 10:37AM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

9

Apr 05, 2022 10:50AM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

5

Apr 05, 2022 11:28AM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

6

Apr 05, 2022 12:07PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

9

Apr 05, 2022 12:51PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

8

Apr 05, 2022 01:56PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

1

Apr 05, 2022 05:52PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

8

Apr 05, 2022 06:04PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

5

Apr 05, 2022 06:13PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

1

Apr 05, 2022 07:22PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

7

Apr 05, 2022 08:13PM

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

2

Apr 06, 2022 06:57AM

dlee38

dlee38

Rank: Mail Room [?]

Points: 165 [?]

Votes: 3 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

in response to

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

by

posted on Apr 06, 2022 08:48AM

Log in to use the IP Check tool ^[?]

I don't know. Hopefully rvx reduces icu admission rate or prevents/stops completely.

9 Recommendations

Loading...

Loading...

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

4

Apr 06, 2022 01:22PM

Reply New Message

Back To Forum List View

Share

Share

Share

Please to post a reply